Intellectual Property UK

  • July 06, 2026

    J&J Bid To Ax US Gov't Blood Cancer Patent Gets March Trial

    A bid by a subsidiary of Johnson & Johnson to revoke a U.S. government patent covering a treatment for a rare form of blood cancer will go to trial in March, a London judge ruled Monday.

  • July 06, 2026

    Wise Payments Keeps TM Due To Rival's Translation Error 

    Wise Payments has cleared a challenge to its "Wise" trademark after European officials rejected a Portuguese property developer's opposition because it failed to provide an English translation outlining the services covered by its own logo.

  • July 03, 2026

    Otis Elevator Patent Rises Above Kone's EPO Attacks

    Otis Elevator has defeated its rival Kone's bid to nix an Otis patent over a system protecting elevator cars from power surges, with an appellate board ruling that other engineers wouldn't have taken the same route. 

  • July 03, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London, Russia's state development bank was sued in a commercial fraud claim involving military GPS technology, one of Nike's subsidiaries brought an intellectual property claim against a menswear company owner, BlackBerry re-opened a $6.49 million claim against its South Asian licensee and CBRE property services filed a claim against CMS Cameron McKenna Nabarro Olswang LLP. 

  • July 03, 2026

    US Biotech Loses UPC Bid To Block Rival's Biopsy Kit Sales

    An American oncology company has failed to persuade a European appeals court to stop a Swiss rival from selling biopsy tests, as judges found the U.S. business had waited too long to seek a preliminary injunction.

  • July 03, 2026

    Fresenius Defeats EU Patent Bid For Dialysis Device

    A Japanese medical device maker has lost a patent over a blood purification device for dialysis patients, failing to prove to European officials that its automated feature that determines whether needles are still connected to a patient was new. 

  • July 03, 2026

    Hotels Biz Loses UK 'Pullman' TM Over Real Estate Services

    Hotels group Accor has lost a trademark over the historic "Pullman" name that covered real estate services, as officials found there was no evidence that it had genuinely used the sign to market broader services such as rental units.

  • July 02, 2026

    Ex-USPTO Deputy Nominated For World IP Org. Leadership

    Laura Peter, who served as U.S. Patent and Trademark Office deputy director under the first Trump administration, has been nominated for the role of deputy director general of the World Intellectual Property Organization's patents and technology sector, the USPTO announced Thursday.

  • July 02, 2026

    EasyGroup Loses 'EasyBathrooms' TM Fight As Markets Differ

    A London judge has refused to let easyGroup block a bathroom design specialist's range of "easy bathrooms" trademarks, concluding that shoppers wouldn't mix up the easyJet owner's low-cost brands with higher-end bathroom products.

  • July 02, 2026

    TotalEnergies' Logo Challenge Runs Out Of Gas

    TotalEnergies has failed to block a Malaysian palm oil producer from registering a curved logo as a trademark, as European officials found consumers would differentiate the energy giant's design because it relied upon a completely different shape and color.

  • July 02, 2026

    Drone Maker Denies Copying US Arms Co.'s Technology

    A British drone maker has pushed back against claims it deliberately copied a U.S. defense contractor's drone design, arguing that the technology is not new because it was already in the public domain before it was patented.

  • July 02, 2026

    Novo Nordisk Blocks Ex-Lead's Use Of Alleged Trade Secrets

    Novo Nordisk secured an injunction Thursday preventing an ex-strategy lead from using for profit or disclosing emails containing information the pharmaceutical company alleges could seriously damage its business, after a London judge concluded there was credible evidence that confidential material might have been taken.

  • July 02, 2026

    Dior Loses Bid To Snuff Out Candlemaker's 'Cerabella' TM

    Christian Dior has failed to block a Spanish candlemaker from registering the trademark "Cerabella," as European officials found consumers would not confuse it with the luxury designer's "Terra Bella" fragrance line.

  • July 01, 2026

    Getty Abandons Shutterstock Buy Amid Spinoff Mandate

    Getty Images opted to abandon its plans to buy Shutterstock rather than sell its rival's editorial arm, in what United Kingdom antitrust enforcers cast as a course reversal after the companies had previously offered up the divestiture to address concerns that the $3.7 billion merger threatened news content competition.

  • July 01, 2026

    LG Electronics Loses EPO Appeal For Video Decoding Patent

    LG Electronics cannot patent a video decompression technique, after failing to convince European appellate officials that a feature simplifying a computation step to obtain key information was inventive at the time.

  • July 01, 2026

    Novartis Faces Generic Challenge To Heart Drug Patent

    Generics drugmaker Stada has asked a London judge to clear the way for it to launch a generic version of Novartis' blockbuster heart failure treatment called Entresto by nixing several of the pharmaceutical giant's patents. 

  • July 01, 2026

    Brewery Hits Back At Distillery Over 'Titanic' Branding 

    A British brewery has rejected claims that selling gin under its "Titanic" label encroached on a distillery's business, arguing that it had been using the branding for decades before the rival business was founded.

  • July 01, 2026

    Sandoz Can't Block Rival's 'Aryuna' TM For Herbal Medicine

    A European court ruled on Wednesday that Sandoz couldn't stop a supplements seller from registering "Aryuna" as a trademark, as shoppers wouldn't think its Armunia-branded birth control pills were somehow linked to the rival's medicinal herbs.

  • July 01, 2026

    Moncler Can't Lock Out German Rival's 'Sigmo' Keyhole TM

    Moncler has failed to persuade European officials to nix a German individual's trademark application for "Sigmo" to sell model trains and other children's toys, as shoppers wouldn't confuse their keyhole-shaped logos.

  • June 30, 2026

    Venezuela Fund Idea Is Covered By NDA Carveouts, Panel Told

    An investment fund manager and a consultancy urged a U.K. appellate court Tuesday to overturn a ruling that they had stolen confidential information to set up a Venezuelan debt investment fund after a joint venture failed.

  • June 30, 2026

    Optis Pushes Top Court To Uphold $502M Apple FRAND Rate

    Counsel for Optis Cellular urged the U.K. Supreme Court on Tuesday to deny Apple's challenge to an order requiring the tech giant to pay $502 million to license a suite of Optis' 4G patents.

  • June 30, 2026

    Takeda Unit Fights Accord's Bid To Nix Crohn's Drug IP

    A unit of pharma giant Takeda has hit back at Accord's bid to invalidate two patents covering treatment regimens for Crohn's disease, arguing that the generic-drug maker is seeking to clear the way for its own competing version in the U.K. market. 

  • June 30, 2026

    Quinn Emanuel Defends Access To UPC Docs On Appeal

    Quinn Emanuel has persuaded an appeals panel at the Unified Patent Court to uphold its right to access documents from Huawei's clash with MediaTek, beating allegations that its application was a "pretext for spying."

  • June 30, 2026

    Cycling Gear Retailer Madison Sues Rival Over 'Roam' Brand

    A leading U.K. distributor of bike parts has accused a Scottish rival of trademark infringement and passing off, selling Roam-branded gear that misleads shoppers familiar with its Madison Roam range.

  • June 30, 2026

    German Football Association Can't Kick Out US Co.'s EU TM

    The German football association has failed to block a U.S. education company's application for a trademark covering its logo after European Union officials ruled that there is no risk of confusion with the governing body's badge.

Expert Analysis

  • Series

    Children's Book Writing Makes Me A Better Lawyer

    Author Photo

    Becoming a children's book author has opened doors to incredible new experiences of which I barely dared to dream, but the process has also changed my life by serving as a reminder that strong writing, networking and public speaking skills are hugely beneficial to a legal career, says Shaunna Bailey at Sheppard Mullin.

  • How The PTAB Landscape Shifted In 2023

    Author Photo

    Attorneys at Finnegan consider the impact of noteworthy Patent Trial and Appeal Board developments in 2023, including rulemaking, litigation, precedential decisions and director reviews that affected PTAB practice, and offer a reference for examining future proceedings and strategies.

  • How 'Copyleft' Licenses May Affect Generative AI Output

    Author Photo

    Open-source software and the copyleft licenses that support it, whereby derivative works must be made available for others to use and modify, have been a boon to the development of artificial intelligence, but could lead to issues for coders who use AI to help write code and may find their resulting work exposed, says William Dearn at HLK.

  • UPC Decision Highlights Key Security Costs Questions

    Author Photo

    While the Unified Patent Court recently ordered NanoString to pay €300,000 as security for Harvard's legal costs in a revocation action dispute, the decision highlights that the outcome of a security for costs application will be highly fact-dependent and that respondents should prepare to set out their financial position in detail, says Tom Brazier at EIP.

  • IP Ruling Could Pave Way For AI Patents In UK

    Author Photo

    If implemented by the U.K. Intellectual Property Office, the High Court's recent ruling in Emotional Perception AI v. Comptroller-General of Patents, holding that artificial neural networks can be patented, could be a first step to welcoming AI patents in the U.K., say Arnie Francis and Alexandra Brodie at Gowling.

  • Why It's Urgent For Pharma Cos. To Halt Counterfeit Meds

    Author Photo

    With over 10.5 million counterfeit medicines seized in the EU in 2023, it is vital both ethically and commercially that pharmaceutical companies take steps to protect against such infringements, including by invoking intellectual property rights protection, says Lars Karnøe at Potter Clarkson.

  • Examining US And Europe Patent Disclosure For AI Inventions

    Author Photo

    As applicants before the U.S. Patent and Trademark Office and the European Patent Office increasingly seek patent protection for inventions relating to artificial intelligence, the applications may require more implementation details than traditional computer-implemented inventions, including disclosure of data and methods used to train the AI systems, say attorneys at Finnegan.

  • Incontinence Drug Ruling Offers Key Patent Drafting Lessons

    Author Photo

    In a long-awaited decision in Astellas v. Teva and Sandoz, an English court found that the patent for a drug used to treat overactive bladder syndrome had not been infringed, highlighting the interaction between patent drafting and litigation strategy, and why claim infringement is as important a consideration as validity, says George McCubbin at Herbert Smith.

  • EPO Decision Significantly Relaxes Patent Priority Approach

    Author Photo

    In a welcome development for patent applicants, a recent European Patent Office decision redefines the way that entitlement to priority is assessed, significantly relaxing the previous approach and making challenges to the right to priority in post-grant opposition proceedings far more difficult, say lawyers at Finnegan.

  • Why US Should Help European Efforts To Fix SEP Licensing

    Author Photo

    The European Commission's proposed reform of standard-essential patent licensing aims to fix a fundamental problem stemming from the asymmetry and obscurity of information about SEPs, and U.S. agencies exploring regulation of foreign regimes should support and improve these efforts, say David McAdams at Duke University and David Katz at WilmerHale.

  • Shifting From Technical To Clear Insurance Contract Wordings

    Author Photo

    Recent developments on insurance policies, including the Financial Conduct Authority's new consumer duty, represent a major shift for insurers and highlight the importance of drafting policies that actively improve understanding, rather than shift the onus onto the end user, say Tamsin Hyland and Jonathan Charwat at RPC.

  • What's In The Plan To Boost Germany's Commercial Litigation

    Author Photo

    Lawyers at Cleary discuss Germany's recent draft bill, which establishes commercial courts and introduces English as a court language in civil proceedings, and analyze whether it accomplishes the country's goal of becoming a more attractive venue for commercial litigation.

  • Bitcoin Case Highlights Advanced Age Of UK's IP Law

    Author Photo

    An appellate court's recent decision in a case involving the copyright of bitcoin's file format emphasizes the role of copyright protection in software, and also the challenges of applying decades-old laws to new technologies, say Marianna Foerg and Ben Bell at Potter Clarkson.

  • Future Paths For AI Inventorship After Justices' Thaler Denial

    Author Photo

    Anup Iyer at Moore & Van Allen examines the current and future state of AI inventorship in the wake of the U.S. Supreme Court's decision not to hear Thaler v. Vidal, including collaboration, international challenges, and the need for closer examination in research and development-intensive sectors.

  • EU Ruling Highlights Strategic Benefits Of Patent Appeals

    Author Photo

    The European Patent Office board of appeal recently reversed the examining board's ruling in an application by LG Electronics, highlighting how applicants struggling to escape conflicting objection traps at the examination level can improve their chances of a positive outcome with an appeal, says Andrew Rudhall at Haseltine Lake.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.